LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia

Autor: Tiu, Ramon V., Visconte, Valeria *, Elson, Paul *, Clemente, Michael J. *, Tabarroki, Ali *, Hasrouni, Edy *, Porter, Amy *, Mooney, Lindsey *, Afable, Manuel G., II *, Englehaupt, Ricki *, Juersivich, Joy *, Cooper, Kathleen *, Sekeres, Mikkael A., Saunthararajah, Yogen, Maciejewski, Jaroslaw P.
Zdroj: In Blood 15 November 2013 122(21):3711-3711
Databáze: ScienceDirect